Catalyst Wire Dossier Catalyst Wire Dossier

Onduarp

telmisartan · Boehringer Ingelheim International GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Onduarp, covering 2014-04-02 to 2014-04-02. Get the full timeline:

Most recent: EMA Withdrawn: Onduarp (telmisartan) — Boehringer Ingelheim International GmbH

See pricing